FIELD: medicine; pharmacology.
SUBSTANCE: to produce composition of common agent, substance or combination of substances, copolymer of lactic and glycolic acid, polysorbate 80 and dimethyl sulfoxide taken in specified ratio are heated at 50÷60°C and mixed to produce homogeneous transparent liquid, which is cooled to room temperature and watered. Produced suspension containing nanoparticles sized 200-400 nm is used according to its intended purpose.
EFFECT: provided technologically available production method of medicinal agents of new generation based on common high-performance and almost non-toxic substances.
4 cl, 4 ex, 5 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| MEDICINAL AGENT BASED ON RYBAFUTIN, AGENT OF ANTIMICROBIC ACTION CONTAINING NANOPARTICLES, AND RELATED METHOD OF PRODUCTION | 2007 |
|
RU2327457C1 |
| D-CYCLOSERINE-BASE DRUG, NANOPARTICLES-CONTAINING PREPARATION OF PROLONGED EFFECT, METHOD FOR ITS PREPARING | 2007 |
|
RU2318513C1 |
| DRUG OF ANTI-TUBERCULOSIS ACTION ON THE BASIS OF D-CYCLOSERINE IN THE FORM OF A LYOPHILISATE AND METHOD OF PRODUCING A MEDICINAL PREPARATION | 2015 |
|
RU2606839C1 |
| RIFAMPICIN-BASED MEDICATION WITH PROLONGED ACTION FOR TREATMENT OF RESISTENT FORMS OF TUBERCULOSIS | 2010 |
|
RU2418585C1 |
| D-CYCLOSERIN-BASED MEDICATION OF PLOLONGED ACTION WITH DOSED RELEASE IN TARGET ORGANS FOR TREATMENT OF RESISTANT FORMS OF TUBERCULOSIS | 2008 |
|
RU2403041C2 |
| ANTITUBERCULOUS COMPOSITION AND METHOD FOR PREPARING IT | 2011 |
|
RU2472512C1 |
| METHOD FOR ESTIMATING ANTIMYCOBACTERIAL ACTION OF ANTI-TUBERCULOSIS DRUGS USING BIOLOGICAL MATERIAL OF PATIENTS WITH PULMONARY TUBERCULOSIS | 2017 |
|
RU2677972C1 |
| ANTI-TUBERCULOSIS MEDICATION BASED ON 4-THIOUREIDOIMINOMETHYLPYRIDINIUM PERCHLORATE, METHOD OF ITS OBTAINING AND METHOD OF TREATMENT | 2010 |
|
RU2423977C1 |
| PHARMACOLOGICAL COMPOSITION WITH ANTI-TUBERCULOSIS ACTION | 2008 |
|
RU2412715C2 |
| METHOD OF TREATING TUBERCULOSIS WITH MULTIPLE DRUG RESISTANCE | 2013 |
|
RU2554753C2 |
